About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Houston | 516 Studies

Clinical Trials Prostate CancerHouston

Prostate Cancer Clinical Trials in Houston

Find 516 clinical trials for prostate cancer near Houston, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 516 trials

TerminatedDocetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyThis randomized phase II trial is studying how well giving docetaxel and prednisone together with or without cediranib works in treating patients with metastatic prostate cancer…NCT00527124·Detroit, Michigan and 3 others CompletedA Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)The purpose of this study is to evaluate the effectiveness, safety and tolerability of nivolumab followed by ipilimumab, in subjects with metastatic castration resistant prostate…NCT02985957·Tucson, Arizona and 58 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPhase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate CancerThe purpose of this study is to conduct a Phase I clinical trial involving in situ RTVP-1 gene therapy for prostate cancer.NCT00403221·Houston, Texas

RecruitingStem Cells for Erectile Dysfunction Post RALPThis is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and…NCT07048314·Houston, Texas

RecruitingHSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate CancerThe purpose of this study is to conduct a Phase I - II clinical trial to extend preclinical studies involving in situ HSV-tk + Valacyclovir gene therapy in combination with…NCT01913106·Houston, Texas

TerminatedLeuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate CancerThis randomized phase I/II trial studies giving leuprolide acetate or goserelin acetate together with or without vismodegib followed by surgery to see how well they work in…NCT01163084·Ann Arbor, Michigan and 4 others

TerminatedAntineoplaston Therapy in Treating Patients With Metastatic Prostate CancerCurrent therapies for Metastatic Pancreatic Cancer provide very limited benefit to the patient.NCT00003533·Houston, Texas

Active not recruitingSunitinib Malate With Hormonal Ablation for Patients Who Will Have ProstatectomyThe goal of this clinical research study is to learn if the addition of sunitinib malate (SU011248) to hormone based castration is an effective treatment for shrinking or…NCT00329043·Houston, Texas

CompletedChemotherapy in Treating Patients With Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004045·Houston, Texas and 1 other

TerminatedHormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate CancerThis study is for men who have prostate cancer and have failed local therapy or are not a candidate for prostatectomy or radiation therapy.NCT02560051·Houston, Texas

CompletedIMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenThe purpose of this study is to show that abiraterone acetate plus prednisone added to the current standard of care, gonadotropin-releasing hormone (GnRH) decreases prostate…NCT01314118·Homewood, Alabama and 44 others

Active not recruitingTempus Priority Study: A Pan-tumor Observational StudyObservational study that will be collecting clinical and molecular health information from cancer patients who have received comprehensive genomic profiling and meet the specific…NCT05179824·Dallas, Texas and 1 other

Enrolling by invitationSocial Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant MenThis study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from…NCT06472817·Atlanta, Georgia and 2 others

WithdrawnQuality of Life in Men With High Risk Localized Prostate CancerPrimary Objectives: 1.NCT00877617·Houston, Texas

Approved for marketingStudy of Abiraterone Acetate in Patients With Advanced Prostate CancerThe purpose of this study is to collect additional safety information on abiraterone acetate administered with prednisone to patients with metastatic castration-resistant prostate…NCT01217697·Birmingham, Alabama and 296 others

CompletedA Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerThe purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.NCT01306890·Bessemer, Alabama and 332 others

CompletedEffectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary CareDiagnostic delays in ambulatory care are often due to breakdowns of related care processes.NCT01346839·Houston, Texas and 1 other

CompletedMTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate CancerThis is a Phase I, non-randomized, multiple-dose, 3+3 dose-escalation study of the safety, pharmacokinetics, biomarkers, preliminary efficacy and patient-reported outcomes of…NCT00868595·Houston, Texas

TerminatedSaracatinib in Treating Patients With Prostate CancerThis randomized phase II clinical trial is studying how well saracatinib works in treating patients with prostate cancer.NCT01267266·Chicago, Illinois and 14 others

CompletedA Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane RegimenThis Phase III, multicenter, randomized, open-label study will evaluate the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 \[anti-PD-L1\] antibody) in…NCT03016312·Duarte, California and 157 others

PreviousPage 5 of 26Next

Other Conditions in Houston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma